|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Phase 1two3
| | | Phone: | (206) 201-2634 | Year Established: | 2008 | Main Contact: | Richard Daifuku, Partner | | Other Contacts: | Neile Grayson, Ph.D., Partner
| |
| Company Description | Phase 1two3 is a consulting firm to the biopharmaceutical industry. Phase 1two3 partners have expertise in drug development from discovery research through Phase III development, as well as business and corporate development. In addition, Phase 1two3 owns a portfolio of intellectual property in the field of oncology.
Phase 1two3 provides hands-on assistance with corporate planning and execution on multiple levels. This includes tasks from annual strategic planning to the more tactical details of executing a business plan or designing a clinical trial. | |
|
|
|
|
|